Novavax (NVAX) Net Margin (2010 - 2026)

Novavax (NVAX) posted quarterly Net Margin of 6.8% for Q1 2026, down 8460.0% year-over-year from 0.08% in Q1 2025, and down 157.11% quarter-over-quarter from 11.91% in Q4 2025.

Novavax (NVAX) Net Margin (2010 - 2026) Analysis & Trends

Novavax's Net Margin history runs 17 years deep, the most recent figure standing at 6.8% for Q1 2026.

  • In Q1 2026, Net Margin fell 8460.0% year-over-year to 6.8%; the TTM figure through Mar 2026 stood at 16.51% (down 5465.0% YoY), while the FY2025 annual figure was 39.19%, up 6668.0% from the prior year.
  • Net Margin for Q1 2026 stood at 6.8%, down from 11.91% in the prior quarter.
  • The five-year high for Net Margin was 77.8% in Q1 2025, with the low at 363.07% in Q1 2023.
  • The 5-year median for Net Margin is 50.99% (2022), against an average of 76.3%.
  • The sharpest annual moves came in 2022 and 2023: Net Margin soared 32987 bps in 2022, then tumbled 39196 bps in 2023.
  • Novavax's Net Margin stood at 50.99% in 2022, then fell by 20 bps to 61.23% in 2023, then slumped by 50 bps to 91.76% in 2024, then surged by 113 bps to 11.91% in 2025, then sank by 157 bps to 6.8% in 2026.
  • Business Quant data shows NVAX's Net Margin at 6.8% in Q1 2026, 11.91% in Q4 2025, and 287.29% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 32.99%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 30.23%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 30.33%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 13.90%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 30.98%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 12.09%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 12.74%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -3.12%
10 Novavax 1.33 Bn 607.37 Mn 42.45 Mn -94.16%

Historic Data

Download Data
DateValue
Jun 30, 2026 -94.16%
Mar 31, 2026 -6.80%
Dec 31, 2025 11.91%
Sep 30, 2025 -287.29%
Jun 30, 2025 60.86%
Mar 31, 2025 77.80%
Dec 31, 2024 -91.76%
Sep 30, 2024 -143.53%
Jun 30, 2024 39.08%
Mar 31, 2024 -157.21%
Dec 31, 2023 -61.23%
Sep 30, 2023 -69.94%
Jun 30, 2023 13.67%
Mar 31, 2023 -363.07%
Dec 31, 2022 -50.99%
Sep 30, 2022 -22.95%
Jun 30, 2022 -274.57%
Mar 31, 2022 28.89%
Dec 31, 2021 -380.87%
Sep 30, 2021 -180.29%